Based on the results of this study, a new therapeutic approach emerges in breast cancer, since overexpression of Nrf2 and NF-κB is associated with malignant cells with a higher histological grade and, thus, inhibition of expression of these factors may provide a promising strategy in the treatment of these patients. The gene discussed is NFKB1; the disease is breast cancer.